[144] Blend Labs, Inc. SEC Filing

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 20,000 common shares through Charles Schwab & Co., Inc. with an aggregate market value of $80,100.00. The shares represent a small portion of the company's outstanding common stock of 255,696,747 shares. The filing lists an approximate sale date of 09/05/2025. The shares were acquired on 06/10/2025 by restricted stock lapse from Blend Labs, Inc., and the consideration is listed as equity compensation. No related sales by the same person in the past three months are reported.

Insights

Securities Analyst

TL;DR: Routine insider notice of planned sale of restricted shares; size is immaterial relative to outstanding stock.

The filing documents a notification under Rule 144 for the proposed sale of 20,000 common shares acquired by restricted stock lapse and designated as equity compensation. The broker is Charles Schwab & Co., Inc. Given the issuer's stated outstanding share count of 255,696,747, the proposed sale equals roughly 0.0078% of outstanding shares, indicating limited direct market impact. The filer reports no other sales in the prior three months, and the notice includes the standard representation about absence of undisclosed material adverse information.

Corporate Governance Specialist

TL;DR: Compliance-focused disclosure; represents standard post-vesting sale notification under Rule 144.

This Form 144 appears to be a compliance filing following lapse of restrictions on equity compensation. It records acquisition and planned disposition details required by Rule 144, including acquisition date, nature of acquisition, payment type, broker, and approximate sale date. The document contains no indication of negative governance events or unusual trading arrangements; it follows typical disclosure practice for insiders selling vested equity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	20000	80100.00	255696747	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2025	Restricted Stock Lapse	BLEND LABS, INC.			20000	06/10/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Blend Labs' (BLND) Form 144 report?

It reports a proposed sale of 20,000 common shares with aggregate market value of $80,100, to be executed through Charles Schwab & Co., Inc.

When were the shares acquired that are being sold under the Form 144?

The shares were acquired on 06/10/2025 through a restricted stock lapse from Blend Labs, Inc.

What is the approximate sale date listed on the Form 144 for BLND?

The approximate date of sale is 09/05/2025 as stated in the filing.

How many shares outstanding does the Form 144 report for BLND?

The filing lists 255,696,747 shares outstanding of common stock.

Did the filer report other sales in the past three months?

No; the filing explicitly states 'Nothing to Report' for securities sold during the past three months.